Dhaouadi T, Riahi A, Ben Abdallah T, Gorgi Y, Sfar I
J Int Med Res. 2024; 52(10):3000605241282116.
PMID: 39397428
PMC: 11529675.
DOI: 10.1177/03000605241282116.
Newman J, Long S, Speake C, Greenbaum C, Cerosaletti K, Rich S
Commun Biol. 2023; 6(1):988.
PMID: 37758901
PMC: 10533491.
DOI: 10.1038/s42003-023-05327-7.
Pang H, Luo S, Huang G, Li X, Xie Z, Zhou Z
Biochem Genet. 2021; 60(4):1222-1235.
PMID: 34822071
DOI: 10.1007/s10528-021-10152-w.
Comba A, Faisal S, Varela M, Hollon T, Al-Holou W, Umemura Y
Front Oncol. 2021; 11:703764.
PMID: 34422657
PMC: 8377724.
DOI: 10.3389/fonc.2021.703764.
VAN Nguyen S, Shamoun L, Landerholm K, Andersson R, Wagsater D, Dimberg J
In Vivo. 2021; 35(2):969-975.
PMID: 33622891
PMC: 8045117.
DOI: 10.21873/invivo.12339.
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.
Wagner M, Jasek M, Karabon L
Front Immunol. 2021; 11:606721.
PMID: 33519815
PMC: 7840570.
DOI: 10.3389/fimmu.2020.606721.
Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
Pan H, Steixner-Kumar A, Seelbach A, Deutsch N, Ronnenberg A, Tapken D
Mol Psychiatry. 2020; 26(6):2471-2482.
PMID: 32089545
PMC: 8440197.
DOI: 10.1038/s41380-020-0672-1.
Reduced GLP-1 response to a meal is associated with the rs3087243 genotype.
Zoka A, Barna G, Nyiro G, Molnar A, Nemeth L, Muzes G
Cent Eur J Immunol. 2020; 44(3):299-306.
PMID: 31933538
PMC: 6953372.
DOI: 10.5114/ceji.2019.89604.
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.
Ma Q, Long W, Xing C, Chu J, Luo M, Wang H
Front Immunol. 2019; 9:2924.
PMID: 30619286
PMC: 6308128.
DOI: 10.3389/fimmu.2018.02924.
Cytotoxic T lymphocyte antigen-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis in the Tunisian population.
Chaouali M, Carvalho A, Tezeghdenti A, Ben Azaiez M, Cunha C, Ghazouani E
Genes Dis. 2018; 5(3):256-262.
PMID: 30320190
PMC: 6176120.
DOI: 10.1016/j.gendis.2017.12.006.
Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance.
Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, Hajizadeh-Saffar E, Farhadi A, Shapiro A
Cell J. 2018; 20(3):294-301.
PMID: 29845781
PMC: 6004986.
DOI: 10.22074/cellj.2018.5513.
CTLA-4 Genetic Variants (rs11571317 and rs3087243): Role in Susceptibility and Progression of Breast Cancer.
Goske M, Ramachander V, Komaravalli P, Rahman P, Rao C, Jahan P
World J Oncol. 2017; 8(5):162-170.
PMID: 29147453
PMC: 5687896.
DOI: 10.14740/wjon1046w.
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.
Queirolo P, Dozin B, Morabito A, Banelli B, Piccioli P, Fava C
Front Immunol. 2017; 8:386.
PMID: 28446908
PMC: 5388686.
DOI: 10.3389/fimmu.2017.00386.
Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells.
Kasela S, Kisand K, Tserel L, Kaleviste E, Remm A, Fischer K
PLoS Genet. 2017; 13(3):e1006643.
PMID: 28248954
PMC: 5352142.
DOI: 10.1371/journal.pgen.1006643.
Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
Guo Y, Gao J, Gao S, Shang M, Guo F
Oncotarget. 2016; 7(17):23088-95.
PMID: 27081086
PMC: 5029612.
DOI: 10.18632/oncotarget.8714.
Variation in the CTLA4 3'UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes.
de Jong V, Zaldumbide A, van der Slik A, Laban S, Koeleman B, Roep B
Genes Immun. 2015; 17(1):75-8.
PMID: 26656450
DOI: 10.1038/gene.2015.51.
Genetic and epigenetic variation in the lineage specification of regulatory T cells.
Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A
Elife. 2015; 4:e07571.
PMID: 26510014
PMC: 4623597.
DOI: 10.7554/eLife.07571.
Investigation of soluble and transmembrane CTLA-4 isoforms in serum and microvesicles.
Esposito L, Hunter K, Clark J, Rainbow D, Stevens H, Denesha J
J Immunol. 2014; 193(2):889-900.
PMID: 24928993
PMC: 4082723.
DOI: 10.4049/jimmunol.1303389.
Molecular mechanisms in autoimmune type 1 diabetes: a critical review.
Xie Z, Chang C, Zhou Z
Clin Rev Allergy Immunol. 2014; 47(2):174-92.
PMID: 24752371
DOI: 10.1007/s12016-014-8422-2.
Common variants on cytotoxic T lymphocyte antigen-4 polymorphisms contributes to type 1 diabetes susceptibility: evidence based on 58 studies.
Wang J, Liu L, Ma J, Sun F, Zhao Z, Gu M
PLoS One. 2014; 9(1):e85982.
PMID: 24465825
PMC: 3900458.
DOI: 10.1371/journal.pone.0085982.